Generic Name: ruxolitinib
Common side effects of Jakafi include: anemia, dizziness, equilibrium disturbance, headache, labyrinthitis, meniere's disease, neutropenia, thrombocytopenia, vertigo, and orthostatic dizziness. Other side effects include: weight gain, and flatulence.  See below for a comprehensive list of adverse effects.
Applies to ruxolitinib: oral tablet
In addition to its needed effects, some unwanted effects may be caused by ruxolitinib (the active ingredient contained in Jakafi). In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking ruxolitinib:
Some of the side effects that can occur with ruxolitinib may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to ruxolitinib: oral tablet
Very common (10% or more): Bruising (up to 23.2%)Common (1% to 10%): Herpes zoster[Ref]
Common (1% to 10%): Flatulence, gastrointestinal bleeding[Ref]
Very common (10% or more): Urinary tract infection (up to 14.4%)[Ref]
Very common (10% or more): Anemia (up to 96.1%), thrombocytopenia (up to 69.8%), neutropenia (up to 18.7%)[Ref]
Common (1% to 10%): Tuberculosis Frequency not reported: Progressive multifocal leukoencephalopathy[Ref]
Very common (10% or more): Hypercholesterolemia (up to 17.4%), weight gain (up to 10%)[Ref]
Very common (10% or more): Dizziness (up to 18.1%), headache (up to 14.8%)Common (1% to 10%): Intracranial bleeding[Ref]
The most common adverse reactions were anemia, thrombocytopenia, bruising, dizziness, and headache.[Ref]
Very common (10% or more): Bleeding (up to 32.6%)[Ref]
Very common (10% or more): ALT increased (up to 27.1%), AST increased (up to 19.3%)[Ref]
1. "Product Information. Jakafi (ruxolitinib)." Incyte Corporation, Wilmington, DE. 
2. Cerner Multum,  Inc. "Australian Product Information." O 0
3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
Not all side effects for Jakafi may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Black, tarry stools
bladder pain
bleeding gums
blood in the urine or stools
bruising
chills
cloudy urine
collection of blood under the skin
cough
deep, dark purple bruise
difficult, burning, or painful urination
fever
frequent urge to urinate
itching, pain, redness, or swelling
large, flat, blue or purplish patches in the skin
lower back or side pain
painful or difficult urination
pale skin
pinpoint red spots on the skin
pus in the urine
shortness of breath
small, red or purple spots on the skin
sore throat
troubled breathing with exertion
ulcers, sores, or white spots in the mouth
unusual bleeding or bruising
unusual tiredness or weakness


Painful blisters on the trunk of the body


Bloated or full feeling
dizziness or lightheadedness
excess air or gas in the stomach or intestines
feeling of constant movement of self or surroundings
headache
passing gas
sensation of spinning
weight gain

